Skip to main content
Sign In
 

Meet the Team


Laurent Gapin, Ph.D.
Flow Cytometry Shared Resource Scientific Director
laurent.gapin@ucdenver.edu

Erin Kitten
Flow Cytometry Shared Resource Manager
erin.kitten@ucdenver.edu
RC1-North, 8207
303-724-8972

Erin graduated from the University of Dallas in 2008 with a BS in Biology. While working in a laboratory at the University of Texas Southwestern from 2007-2010, Erin acquired scientific expertise in cell biology focused on projects relating to telomeres and telomerase and protection from space irradiation. At Texas Tech University from 2010-2015, Erin's research focused on the role of formins in microtubule capture at the lytic synapse and migration in natural killer cells. Erin also acquired experience in the culturing, maintenance and differentiation of induced pluripotent stem cell (iPSC) through her role as a Professional Research Assistant (PRA) at the CU Anschutz Medical Center Charles C. Gates Center for Regenerative Medicine. 
 
In the context of flow cytometry, Erin earned BD FACSAria Operator certification and an Expert Cytometry Mastery Certification to solidify her technical knowledge. Erin's knowledge and training allow her to operate the instruments (BD FACSAria Fusion sorter, BDFACS LSR Fortessa and a Beckman Coulter CytoFlex) within the facility, train users and troubleshoot technical issues that arise during use. 
 
As the Manager of the Flow Cytometry Shared Resource Laboratory (SRL) for the Department of Immunology and Microbiology and the Human Immunology and Immunotherapy Initiative (HI3), Human Immune Monitoring Shared Resource (HIMSR), Erin utilizes her experience in cell biology and expertise in cytometry to provide training, technical resources and opportunities to the faculty, post-docs and students that utilize the Flow Cytometry SRL. Erin is interested in advancing cytometry methodology by providing experimental design support and/or helping users to expand their panels through the incorporation of new fluorophores. Erin is also interested in expanding capability through the implementation of innovative techniques that include RNA flow, bead-based immunoassays and CyTOF.